Journal
AMERICAN JOURNAL OF OPHTHALMOLOGY
Volume 131, Issue 6, Pages 788-791Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/S0002-9394(00)00959-4
Keywords
-
Categories
Funding
- PHS HHS [UIO E406284] Funding Source: Medline
Ask authors/readers for more resources
PURPOSE: To evaluate choroidal melanomas in enucleated eyes for the presence of type I estrogen receptors. METHODS: Fourteen consecutive eyes with large choroidal melanomas (defined as >16-mm basal diameter and >8 mm thickness) from 14 patients (eight women and six men with a mean age of 57 years; range, 25-74 years) enucleated in accordance with the Collaborative Ocular Melanoma Study (COMS) protocol were investigated. Immunohistochemical techniques were employed to label the choroidal melanomas for the presence of type I estrogen receptors. Each specimen was then evaluated in a masked fashion by an experienced ophthalmic pathologist for positive nuclear staining. RESULTS: No tumors showed immunohistochemical evidence of a type I estrogen receptor. CONCLUSION: Type I estrogen receptors are not present in choroidal melanoma. Estrogens are not likely to influence choroidal melanoma growth through traditional receptors. (Am J Ophthalmol 2001;131:788-791. (C) 2001 by Elsevier Science Inc. All rights reserved.).
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available